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S U M M A R Y
Objectives: In the light of international experience and guidelines and in order to improve the quality of
perioperative antimicrobial prophylaxis (PAP), various hospitals have set up their own multidisciplinary
healthcare teams and have evaluated the density of PAP through close supervision and interventions.
The aim of the present study was to compare the density, quality, and cost of PAP before and after an
intervention implemented at our hospital in order to increase the quality of PAP.
Methods: PAP was monitored using a form prepared in line with the international guidelines, which was
completed by the infection control nurse under the supervision of the infectious diseases specialist. In
order to reduce the frequent errors in our PAP procedures, an intervention was implemented, and the
period before this intervention (January–April 2011) was compared with the post-intervention period 1
year later (January–April 2012). The density of PAP was calculated according to the Anatomical
Therapeutic Chemical classiﬁcation/deﬁned daily dose (ATC/DDD) methodology.
Results: A total of 2398 patients received PAP during this period. The most frequently used antibiotic
before and after the intervention was cefazolin. Its use further increased after the intervention
(p < 0.001). After the intervention, the ratio of the correct timing of the ﬁrst antibiotic dose increased
from 91.7% to 99.0% (p < 0.001), while the excessively long administration of PAP was reduced from
77.0% to 44.7% (p < 0.001). The ratio of full compliance with the guidelines increased from 15.5% to 40.2%
(p < 0.001) and the rate of surgical site infections dropped from 18.5% to 12.0%. The density of antibiotic
use dropped from 305.7 DDD/100 procedures = 3.1 DDD/procedure to 162.1 DDD/100 procedures = 1.6
DDD/procedure.
Conclusion: The quality of PAP may be improved through better compliance with healthcare guidelines,
close supervision, and training activities. Also, surgical site infections and the cost of PAP may be reduced
through more appropriate antibiotic use, thus contributing to the national healthcare budget.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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In the light of international experience and guidelines related
to perioperative antimicrobial prophylaxis (PAP), various coun-
tries have published their own consensus guidelines.1–3 Also, in
order to improve the quality of PAP, numerous hospitals have
established their own multidisciplinary healthcare teams togeth-
er with local guidelines and training activities based on the
international experience and criteria.2,4 However, in spite of the
implementation of these measures, studies have reported that
unnecessary antibiotic use for PAP is still a widespread problem* Corresponding author. Tel.: +90 412 248 80 01 ext. 4903;
fax: +90 412 248 84 40.
E-mail address: drfatmayakut@hotmail.com (F. Bozkurt).
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http://dx.doi.org/10.1016/j.ijid.2013.08.003around the world. Problems such as the inappropriate selection of
a broad-spectrum antibiotic, the administration of PAP for longer
than necessary, and the wrong timing of the prophylaxis, all
increase surgical site infection (SSI) rates and healthcare costs.5,6
Therefore, the quality and use of PAP have been the focus of
various controlled studies. Such studies evaluating the density of
antibiotic use can supply valuable information on the appropriate
and effective administration of PAP. Although some studies have
pointed to the inappropriate use of antibiotics and the associated
costs in hospitals in Turkey, studies evaluating the density,
quality, and cost of surgical prophylaxis are limited in number and
they have underlined the need to establish compliance with the
guidelines, as well as engaging in training activities, in order to
increase the quality of PAP.7–11 In the light of these recommenda-
tions, an intervention was planned and implemented to improve
the quality of PAP and to adopt the international guidelines in ourses. Published by Elsevier Ltd. All rights reserved.
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compared to the post-intervention period.
2. Methods
The Diyarbakir Training and Research Hospital is a new
establishment with 672 beds, six intensive care units, 10 medical
clinics, and eight surgical clinics. The hospital started to admit
patients in July 2010 and is a reference hospital providing
healthcare services to the South-East Anatolian region of Turkey.
In this hospital, surgical prophylaxis was carried out using a
form prepared by the infection control committee (ICC) based on
international guidelines, which was completed by the infection
control nurse (ICN) under the supervision of the responsible
infectious diseases control specialist (IDCS). When the forms that
had been completed over a 4-month period were evaluated, the
need for an intervention became apparent due to the frequent
mistakes made in the surgical prophylactic procedures. In order to
achieve an effective intervention, it was decided to bring about a
synergy with the surgical departments and to plan the intervention
in coordination with the surgeons. Thus, a surgeon was appointed
for every surgical unit and a series of meetings were held together
with the ICC. During these meetings, the following decisions were
made: (1) The valid international guidelines should be adopted by
our hospital. (2) The indication for surgical prophylaxis, the type of
antibiotic to be used, and the dose and duration of treatment
should be determined by the surgeon performing the surgery. (3)
In order to administer the antibiotic at the correct point in time, the
anesthesia technician instead of the ward nurse should be
responsible for the initial prophylactic antibiotic dose. All these
decisions were announced to all the surgeons, and regular
observations were made for 8 months. Thus, ICNs were accompa-
nied by the IDCS twice a week at the daily clinic visits and the
observation results were shared with the physicians in every clinic.
The frequency of inspections and feedback was increased in the
clinics where compliance with the guidelines was observed to be
low. Also, monthly training seminars were given on antibiotic
prophylaxis in surgical procedures. Following the 8-month
intervention period, surgical prophylaxis monitoring forms were
again completed for 4 months. The pre-intervention period was
then compared to the post-intervention period.
The classiﬁcation of the surgical site was made according to the
USA National Research Council’s modiﬁed wound classiﬁcation
criteria.1,2 While no prophylactic antibiotic treatment is recom-
mended for clean surgical procedures, prophylactic antibiotic use
is recommended in procedures involving prostheses in order to
prevent serious complications that may occur due to a prosthesis
infection in the wake of the surgery.1–3,12 In the general surgery,
thoracic surgery, head and neck surgery, neurosurgery, cardio-
vascular surgery, plastic surgery, orthopedic, and urology clinics,
the following information was collected using the forms and was
analyzed retrospectively: patient demographics, admission and
discharge dates, date of surgery, any allergies to beta-lactam
antibiotics, type and duration of surgery, wound contamination
classiﬁcation, perioperative antibiotic selected, dose of the
chosen antibiotic, total number of prophylactic antibiotic doses,
duration of prophylaxis, timing of the initial antibiotic dose, the
subsequent doses, any antibiotic subscriptions after discharge,
and any infections at the surgical site.
The cost of the antibiotics used for every surgical prophylaxis
was calculated according to the daily prices of medication in
Turkey. The total cost in the pre- and post-intervention period was
calculated in Euros based on the exchange rates in Turkey. The
exchange rate for the Euro before the intervention was taken as 1
Euro = 2.13 Turkish Lira, while it was taken as 1 Euro = 2.34 Turkish
Lira after the intervention. Surgeries classiﬁed as ‘dirty’ or‘contaminated’, patients with an infection before surgery, and
those already on antibiotic treatment were excluded from the
study.
The prophylactic antibiotics administered, type of antibiotic,
time of administration, the duration and dose, and any additional
doses in relation to the duration of surgery were analyzed in terms
of compliance with the international guidelines. The guidelines
recommend the administration of a non-toxic and low-cost
narrow-spectrum antibiotic with rapid action, or an intravenous
single-dose bolus within 30–60 min before the incision. If the
selected antibiotic is vancomycin or ﬂuoroquinolone, it is
recommended that this is administered as a 1-h slow infusion
1–2 h before the incision. Vancomycin is recommended as the ﬁrst
choice antibiotic if the rates of methicillin-resistant Staphylococcus
epidermidis or Staphylococcus aureus infection are known or
thought to be high, if the patient has a life-threatening beta-
lactam allergy, or if large-scale surgery involving a metal
prosthesis is planned; for all other cases, a ﬁrst- or second-
generation cephalosporin (cefazolin or cefuroxime) is recom-
mended as the antibiotic of ﬁrst choice. If prophylaxis against
anaerobic bacteria is required, it is recommended that metronida-
zole is added to the ﬁrst- or second-generation cephalosporin. Also,
if the blood loss during surgery exceeds 1500 ml or if the duration
of the surgery is longer than 240 min, additional doses of
antibiotics are recommended. Finally, it is recommended that
the duration of prophylaxis with antibiotics is no longer than 24 h,
except in cardiothoracic surgery, where it is 72 h.1–3,12
In the light of these recommendations speciﬁed in the
international guidelines, the appropriate application of surgical
prophylaxis was evaluated according to ﬁve criteria: (1) the correct
indication for PAP; (2) selection of a suitable agent; (3) optimal
time point for the initiation of treatment; (4) number of doses; (5)
appropriate duration of treatment.
Two infectious diseases specialists (the ﬁrst two authors) and a
surgeon evaluated the compliance of PAP with the international
criteria. If PAP was in full compliance with the international
guidelines, it was evaluated as appropriate; any PAP application
not fulﬁlling these criteria was deemed inappropriate.
The use of antibiotics was analyzed through the quantitative
calculation of the deﬁned daily dose (DDD) for every 100
procedures. For this purpose, the Anatomical Therapeutic Chemical
(ATC) classiﬁcation/DDD index (2010), prepared with the collabo-
ration of the World Health Organization Collaborating Centre for
Drug Statistics Methodology, was used.13 The DDD values were
obtained through the division of the total amount of the daily
antibiotics used for every procedure by the DDD equivalent for that
antibiotic in the ATC/DDD system.
The diagnosis of the SSI was made in accordance with the
criteria of the US Centers for Disease Control and Prevention
(CDC).1 The SSI rates were evaluated based on the clinic and
outpatient clinic records within 1 year following surgery. All data
were coded and entered into an Excel ﬁle, which was analyzed
using SPSS 15.0 software package (SPSS Inc., Chicago, IL, USA).
During the statistical analysis of the pre- and post-intervention
data, categorical data were compared using the Chi-square test,
while numeric data were compared through the Student’s t-test. A
value of p < 0.05 was accepted as statistically signiﬁcant.
3. Results
In the 4-month pre-intervention period, 2977 procedures in
eight surgical clinics were evaluated, and in the 4-month post-
intervention period, 2654 procedures were evaluated; 1211 and
1187 procedures, respectively, were found to fulﬁll the study
criteria for inclusion. The demographic characteristics of the
patients are presented in Table 1.
Table 1
Patient characteristics pre- and post-intervention
Variable Pre-intervention Post-intervention p-Value
No. of patients 1211 1187 0.512
Male/female 565/646 573/614 0.428
Age, years, mean  SD 43.4  20.2 45.9  19.9 0.182
Surgical site class
Clean 621 547 0.011
Clean-contaminated 590 640
SD, standard deviation.
F. Bozkurt et al. / International Journal of Infectious Diseases 17 (2013) e1212–e1217e12143.1. Evaluation of PAP
Before the intervention, 1139 (94.1%) patients received PAP and
120 (10.5%) patients had no indication for it. After the intervention,
1151 (96.7%) patients received PAP and 40 (3.5%) patients had no
indication for it (Table 2).
3.2. Selection of the antibiotic
During the pre-intervention period a single antibiotic was
used in 1063 (87.8%) procedures, and during the post-interven-
tion period a single antibiotic was used in 1142 (96.2%)
procedures. This difference was statistically signiﬁcant
(p < 0.001) (Table 2). During both periods, the most frequently
used antibiotic was cefazolin, which was administered in 707
(62.1%) and 938 (81.5%) procedures, respectively (p < 0.001)
(Table 2).
3.3. Timing and route of administration
The route of administration was intravenous in all procedures
before and after the intervention (100%). The administration of PAP
occurred within the recommended period (30–60 min before the
incision and during the induction of anesthesia) in 91.7% and 99.0%
of patients in the pre- and post-intervention groups, respectively.Table 2
Perioperative antimicrobial prophylaxis (PAP) in surgical procedures pre- and post-int
Parameter Pre-intervention 
Number recorded (%) Number ap
Antibiotic use
Yes 1139 (94.05) 1019 (89.4
No 72 (5.95) 62 (82.6
Indication for PAP
Yes 1029 (84.97) 1019 (84.1
No 187 (15.02) 62 (51.1
Total 1019 (84.1
Antibiotic of choice
Cefazolin 707 (62.1) 707 (100
Cefuroxime 177 (15.5) 177 (100
Ceftriaxone 130 (11.4) 16 (12.3
SAM 68 (6.0) 0 (0) 
Ciproﬂoxacin 30 (2.6) 4 (13.3
Vancomycin 27 (2.4) 6 (22.2
Total 910 (79.0
Single antimicrobial agent 991 (87) 514 (51.8
Combination (two antimicrobial agents) 148 (13) 0 (0) 
Timing of the ﬁrst dose
At the time of the induction of anesthesia 525 (46.1) 525 (100
30–60 min before the incision 519 (45.56) 519 (100
Postoperative 95 (8.34) 0 (0) 
Total 1044 (91.6
Duration of PAP
Single dose (h) 106 (9.3) 106 (100
<24 156 (13.7) 156 (100
>24 877 (77) 
Antibiotic use after discharge 219 (18.1) 0 (0) 
Total 1139 (100) 124 (10.8
SAM, sulbactam/ampicillin.This difference was statistically signiﬁcant (p < 0.001) (Table 2).
The timing was inappropriate in 95 (8.3%) and 11 (1.0%) patients,
respectively.
3.4. Duration of treatment
The mean duration of PAP was 4.3  3.0 days during the pre-
intervention period and 2.3  2.3 days during the post-intervention
period. This difference was statistically signiﬁcant (p < 0.001). In the
majority of procedures, the antibiotic prophylaxis was unnecessarily
long. PAP was inappropriately long in 877 (77.0%) of the 1139 patients
in the pre-intervention period, and in 515 (44.7%) of the 1151 patients
in the post-intervention period. This difference was statistically
signiﬁcant (p < 0.001) (Table 2).
3.5. Post-discharge antibiotic treatment
From the pre-intervention period to the post-intervention
period, the ratio of surgeons prescribing oral antibiotics as a
continuation of the prophylaxis was reduced from 211/1211
(17.4%) to 65/1187 (5.5%). This difference was statistically
signiﬁcant (p < 0.001) (Table 2).
3.6. Surgical site infections
The ratio of SSI in clean surgeries before and after the
intervention was reduced from 54/1211 (4.5%) to 11/1187
(0.9%). This ratio diminished from 173/1211 (14.3%) to 54/1211
(4.5%) after clean-contaminated surgeries. This difference was
statistically signiﬁcant (p < 0.001).
3.7. Calculation of the DDD density per operation
During the pre- and post-intervention periods, when the
amount given in one administration in every procedure is deﬁned
as a dose (mg, g), the average of the total dose for every procedureervention
Post-intervention p-Value
propriate (%) Number recorded (%) Number appropriate (%)
6) 1151 (96.7) 1111 (96.52) 0.512
6) 36 (3.3) 33 (91.66)
4) 1114 (93.85) 1111 (93.59) 0.458
9) 73 (6.15) 33 (2.78)
4) 1111 (93.59)
) 938 (81.5) 938 (100) <0.001
) 104 (9.1) 104 (100)
0) 60 (5.2) 18 (30)
14 (1.2) 0 (0)
3) 22 (1.9) 5 (22.72)
2) 13 (1.1) 5 (38.46)
6) 1070 (92.96)
6) 1109 (96.35) 922 (51.86) <0.001
42 (3.65) 0 (0) <0.001
) 758 (65.85) 758 (100)
) 382 (33.19) <0.001
11 (0.96) 0 (0)
5) 1140 (99.04)
) 244 (21.2) 244 (100)
) 392 (34.1) 392 (100)
0 (0) 515 (44.7) <0.001
65 (5.5) 0 (0) <0.001
8) 1151 (100) 433 (37.61) <0.001
Table 3
Number of DDD/100 operations in the pre-intervention period
ATC GS TS HNS NS CVS Ort PS Uro
Cefazolin J01DB04 231.8 272.9 96.9 372.8 206.6 82.5 24.1 25.9
Cefuroxime J01DC02 4.6 21.0 18.9 30.1 82.2 - 30.9
Ceftriaxone J01DD04 48.5 89.4 21.6 65.3 - 16.5 20.9 38.2
SAM J01CR01 25.1 47.4 40.5 54.4 - 29.4 - -
Ciproﬂoxacin J01MA02 - - - - - - 55.5
Gentamicin J01GB03 - - - - - 64.8 - -
Metronidazole J01XD01 29.0 - - - - - -
Clindamycin J01FF01 15.2 46.3 21.6 - - 35.6
Vancomycin J01XA01 - - - - - 48.1
Total 354.2 477.0 199.5 522.6 288.8 276.9 75.9 119.6
DDD, deﬁned daily dose; ATC, Anatomical Therapeutic Chemical classiﬁcation; SAM, sulbactam/ampicillin; GS, general surgery; TS, thoracic surgery; HNS, head and neck
surgery; NS, neurosurgery; CVS, cardiovascular surgery; Ort, orthopedics; PS, plastic surgery; Uro, urology.
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difference was statistically signiﬁcant (p < 0.001). According to the
ATC/DDD system, the density of antibiotic use was 305.7 DDD/100
procedures in the pre-intervention period and 162.1 DDD/100
procedures in the post-intervention period. This ratio was 3.1 DDD
and 1.6 DDD for a single procedure, respectively (Table 4).
While the density of antibiotic use before the intervention
was higher in the neurosurgery, thoracic surgery, general
surgery, and cardiovascular surgery departments compared to
the other surgical units (Table 3), after the intervention, the
density of antibiotic use was higher in the general surgery,
neurosurgery, orthopedic, and thoracic surgery departments
(Table 5). Also, while cefazolin, which was the most frequently
used antibiotic before and after the intervention, was followed
by ceftriaxone and ampicillin/sulbactam before the intervention,
it was followed by cefuroxime and ceftriaxone after the
intervention (Table 4).
3.8. Costs
For every single procedure, the mean cost of the prophylactic
antibiotic use was reduced from the pre-intervention 30.1 Euros
(during the study period, the total for all the procedures was
36 420 Euros) to 18.1 Euros after the intervention (during the study
period, the total for all procedures was 21 465 Euros). This
difference was statistically signiﬁcant (p < 0.001).
4. Discussion
Our study is a pioneering one in our country in terms of a
successful intervention implemented to raise the quality of PAP.
Also, the use of the recently popularized ATC/DDD methodology,
which enables a comparison of the density of prophylactic
antibiotic use between our hospital and other national andTable 4
Consumption of anti-infectives in total and by ATC group at a hospital in Turkey, 2011
Anti-infectives ATC code Pre-intervention
ACI
Post-intervention
ACI
Pre
abs
Cefazolin J01DB04 178.7 110.5 
Cefuroxime J01DC02 12.7 13.4 
Ceftriaxone J01DD04 52.6 12.8 
SAM J01CR01 27.8 6.2 
Ciproﬂoxacin J01MA02 5 7.4 
Gentamicin J01GB03 5.4 7.1 
Metronidazole J01XD01 2.4 
Clindamycin J01FF01 17.1 
Vancomycin J01XA01 4 3.7 1
Total 305.7 162.1 2
DDD, deﬁned daily dose; ATC, Anatomical Therapeutic Chemical classiﬁcation; SAM, sulinternational hospitals, gave us the chance to contribute new
data from Turkey.
Although there are various national and international guide-
lines aiming to increase the quality of PAP, total compliance with
these varies between countries. In fact, studies have shown that
compliance leaves a lot to be desired around the world. While total
compliance with the guidelines has been shown to be below 1% in
Iran14 and Korea,15 it was observed to be 28% in a Dutch study,5
33.2% in a Malaysian study,16 36.3% in a Greek study,17 and 41.1% in
a French study.18
Before the intervention, total compliance with the international
guidelines in our hospital (15.4%) was close to the compliance rates
of various hospitals in our country (19.7–13.9%).8,19 Following the
intervention, this rate (39.3%) showed a statistically signiﬁcant
increase. However, the fact that compliance rates in certain
countries are much higher even before any intervention (50–95%)
than at our hospital after the intervention, and have risen to levels
close to 100% after interventions,20–22 indicates that the quality of
PAP is still too low in our hospital. Although the efﬁciency of our
intervention in this respect should not be disregarded, we are of
the opinion that we should plan further interventions to improve
compliance.
The calculation of antibiotic consumption for PAP using the
ATC/DDD system is important in terms of achieving a standardi-
zation to compare antibiotic consumption rates of hospitals at the
national and international level. While the antibiotic consump-
tion rate at our hospital before the intervention (305.7 DDD/100
operations) was similar to the consumption rates in other
hospitals in our country (282.3 and 330.2 DDD/100 opera-
tions),8,14 after the intervention, a statistically signiﬁcant reduc-
tion to 162.1 DDD/100 operations was observed (p < 0.001).
Similar to our study, an intervention in Germany has been
reported to reduce the antibiotic consumption rate from 121 to 79
DDD/100 operations.4 Another study conducted in Japan has also and 2012
- to post-intervention
olute change (%)
Pre-intervention
percentage of total use
Post-intervention
percentage of total use
67.5 (37.9) 58.5 68.1
0.68 (5.36) 4.1 8.3
39.8 (75.7) 17.2 7.9
21.1 (75.8) 9.1 3.8
2.46 (49.7) 1.6 4.6
1.72 (32.1) 1.8 4.4
0.8
16.1 (94.4) 5.6 0.6
43.4 (47) 1.3 2.3
83 100 100
bactam/ampicillin; ACI, antimicrobial consumption index (DDD per 100 bed-days).
Table 5
Number of DDD/100 operations in the post-intervention period
ATC GS TS HNS NS CVS Ort PS Uro
Cefazolin J01DB04 228.8 140.47 35.81 146.66 41.08 93.13 35.47 35.97
Cefuroxime J01DC02 10.9 23.01 31.95 - 62.01 - 16.45 -
Ceftriaxone J01DD04 9.32 - 12.3 - - - 36.85 36.50
SAM J01CR01 9.6 - - 34.78 - - - -
Ciproﬂoxacin J01MA02 - - - - - - - 0.39
Gentamicin J01GB03 - - - - - 50.9 - -
Metronidazole J01XD01 - - - - - - - -
Clindamycin J01FF01 3.2 - - - - - - -
Vancomycin J01XA01 - - - - - 29.62 - -
Total 261.8 163.4 80.0 181.4 103.09 173.65 88.77 72.86
DDD, deﬁned daily dose; ATC, Anatomical Therapeutic Chemical classiﬁcation; SAM, sulbactam/ampicillin; GS, general surgery; TS, thoracic surgery; HNS, head and neck
surgery; NS, neurosurgery; CVS, cardiovascular surgery; Ort, orthopedics; PS, plastic surgery; Uro, urology.
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100 operations.23
Considering that the international guidelines permit prophy-
lactic antibiotic use to be extended up to 72 h in cardiovascular
surgery2 and thus the antibiotic consumption in the cardiovascu-
lar surgery department is expected to be higher than in other
clinics, in our hospital, the highest consumption rates were
observed in the neurosurgery clinic before the intervention (522.6
DDD/100 operations) and in the general surgery clinic after the
intervention (261.8 DDD/100 operations). The reason for this was
the administration of PAP for over 24 h (87.2% and 62.7%,
respectively).
It has been demonstrated in some studies that the majority of
surgeons tend to extend the duration of antimicrobial prophylaxis
longer than the recommended period.7,8,23,24 In a nationwide study
conducted in Turkey in 2003, Hosoglu et al. emphasized that only
20% of all surgeons administered PAP for the recommended
duration.7 While compliance in terms of the duration of PAP is
reported to be 65.8–82% in certain countries,5,23 the rate of non-
compliance has been reported at between 56.9% and 80% in our
country.7,9,14 In our hospital, the rate of non-compliance in terms
of the duration of PAP in the pre- and post-intervention periods
was reduced from 77.0% to 44.7% (p < 0.001). Still, one of the main
problems of PAP both at our hospital and in our country is the
extended length of the treatment.
As well as the use of strictly aseptic conditions, the
administration of antimicrobial prophylaxis in order to maintain
an adequate antibiotic concentration in the tissue before the
incision is made is important to control colonization at the surgical
site and to prevent SSIs. Studies have shown that two-thirds of SSIs
can be prevented through the administration of PAP at the right
point in time.1,25 In our study, compliance of the antibiotic chosen
for PAP with the international guidelines increased from 91.7% to
99% (p < 0.001). In other hospitals in our country, the correct
timing of PAP varies between 59.2% and 94.5%.8,19
A lack of awareness or coordination, and resistance to comply
with the recommendations in the guidelines are some of the
obstacles in the way of developing PAP applications. An appropri-
ate intervention and a collaborative approach are important to
improve compliance with the standard protocols.26 In order to
overcome these obstacles, we needed to establish good coordina-
tion with the surgeons. Therefore, we planned the intervention
together with the surgery departments and supported our
coordination with clinical observations, feedback, and informative
meetings.
It has also been shown that the ratio of SSIs can be reduced
through a limitation of PAP and optimized interventions.4,24,27 In
our study, full compliance with the guidelines achieved through an
effective intervention, reduced the rate of SSIs from 18.5% to 12.0%
(p < 0.001). This result shows that interventions, close monitoring,and compliance with the international guidelines are effective
measures for the improvement of PAP.
One of the most critical aspects of an appropriate PAP is the
choice of suitable antibiotic. In general, ﬁrst- and second-
generation cephalosporins are recommended for surgical prophy-
laxis.1–3,12 In our study, the rate of suitable antibiotic selection
increased from 77.6% to 90.6% after the intervention (p < 0.001).
Previous studies have revealed a wide range for the use of ﬁrst-
generation cephalosporins (11–85.8%).7–10
Studies have shown that SSIs can be reduced by increasing the
quality of PAP, which will also contribute to the national healthcare
budget.4,24 If 1 g of cefazolin had been given for every procedure, as
recommended by the international guidelines, the cost of the
prophylactic antibiotic for every procedure at our hospital would
have been 2.34 Euros before the intervention and 2.13 Euros after
the intervention, thus reducing the total cost by 92% and 88%, from
36 420/21 465 Euros to 2833.7/2531.9 Euros. A study analyzing the
costs in Turkey has reported the mean cost per procedure to be
18.6 Euros.19 Another study conducted in the Netherlands has
reported a 25% reduction in the cost per procedure from 11 Euros
to 8.2 Euros.4 Similarly, in our study, the cost of every procedure
was reduced by 39.9% from the pre-intervention 30.1 Euros to 18.1
Euros after the intervention (p < 0.001).
One of the inappropriate applications in our hospital was the
prescription of oral antibiotics subsequent to PAP as the
continuation of the prophylaxis. Following our intervention, the
prescription rate of oral antibiotics diminished from 17.4% to 5.5%
(p < 0.001). A similar situation has been observed in a study
conducted in Korea, and a much higher oral antibiotic prescription
rate (60.3%) after discharge has been reported.15
Improving the quality of antibiotic treatment in PAP also
improves the quality of healthcare and reduces the cost of PAP for
every procedure.22 Reaching a consensus in the national guidelines
on the application of PAP is the main step towards improving the
quality of antibiotic use. However, national guidelines for Turkey
are yet to be published.
Like every clinical study, our study has certain limitations. The
greatest limitation of our study is the fact that it was conducted at a
single center. Another limitation was the lack of local guidelines
due to our limited data on antibiograms, resulting from the very
recent establishment of our microbiology laboratory. However, the
current international guidelines are in use in various centers
including our hospital and they have been demonstrated to be
efﬁcient in improving the quality of PAP.9,11,19 Additionally there
was signiﬁcant difference between clean and clean-contaminated
operations in the pre- and post-intervention periods.
In conclusion, in this prospective study, every step of PAP was
correctly applied in only 27.9% of procedures. We observed a
strong trend towards excessive antibiotic use for PAP. We have
demonstrated that the rate of SSIs and the ﬁnancial burden can be
F. Bozkurt et al. / International Journal of Infectious Diseases 17 (2013) e1212–e1217 e1217reduced by counteracting this trend. Therefore, we are of the
opinion that evaluating the density of PAP is also valuable in terms
of emphasizing the positive outcome to be obtained by increasing
the quality of PAP.
Conﬂict of interest: No conﬂict of interest to declare.
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